Medical Oncologist, specializing in Gastrointestinal Cancers
Dr. Heinz-Josef Lenz, MD, is a globally respected medical oncologist and cancer researcher specializing in gastrointestinal malignancies at the USC Norris Comprehensive Cancer Center. He holds the H. Leslie and Elaine S. Hoffman Chair in Cancer Research and is Co-Director of the USC Center for Cancer Drug Development. In addition, he is a Professor of Medicine and Preventive Medicine at the Keck School of Medicine of USC. Dr. Lenz earned his medical degree from Johannes Gutenberg University in Mainz, Germany, and completed training in internal medicine and oncology both in Germany and the United States. Board-certified in medical oncology, he offers expert care for patients with colorectal, gastric, and pancreatic cancers.
Dr. Lenz is internationally recognized for his leadership in cancer pharmacogenomics and precision oncology. His groundbreaking research has advanced the understanding of how molecular and genetic markers influence response to cancer therapy, leading to the development of more personalized treatment strategies. As principal investigator of numerous clinical trials, he has played a key role in integrating genomic insights into the clinical management of gastrointestinal cancers. He has authored over 400 peer-reviewed publications and is a frequent speaker at major international oncology conferences.
Beyond his clinical and research achievements, Dr. Lenz is a committed educator and mentor, shaping the next generation of cancer scientists and clinicians. He serves on multiple editorial boards and contributes to national and international cancer research networks. His multidisciplinary approach and commitment to translational research continue to impact cancer care worldwide, solidifying his reputation as a leader in gastrointestinal oncology and personalized medicine.
Health insurance plans can change over time. If your plan isn't listed below, it may still be accepted by this doctor. Always contact the doctor's office to confirm your coverage.